Home  /  Resource Library  /  Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial

Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial

Results of a study investigating CAR T axicabtagene ciloleucel with rituximab for treatment of relapsed DLBCL.